SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-15-023062
Filing Date
2015-04-15
Accepted
2015-04-15 17:24:12
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A v407045_10ka.htm 10-K/A 788795
2 EXHIBIT 23.1 v407045_ex23-1.htm EX-23.1 2837
3 EXHIBIT 31.1 v407045_ex31-1.htm EX-31.1 10685
4 EXHIBIT 31.2 v407045_ex31-2.htm EX-31.2 10751
5 EXHIBIT 32.1 v407045_ex32-1.htm EX-32.1 5803
6 EXHIBIT 32.2 v407045_ex32-2.htm EX-32.2 5898
7 GRAPHIC tpg11a.jpg GRAPHIC 52633
8 GRAPHIC tpg11b.jpg GRAPHIC 33098
9 GRAPHIC tpg12a.jpg GRAPHIC 21587
10 GRAPHIC tpg12b.jpg GRAPHIC 23246
11 GRAPHIC tpg15.jpg GRAPHIC 12300
  Complete submission text file 0001144204-15-023062.txt   1023426
Mailing Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060
Business Address 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA 23060 650-888-2422
AmpliPhi Biosciences Corp (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-23930 | Film No.: 15772630
SIC: 2836 Biological Products, (No Diagnostic Substances)